Insider · CIK 0001766032

Beaulieu Joseph

Reports to the SEC for 1 company · CAMBRIDGE, MA

sec.gov

Transactions

Companies

Filings

CIK

0001766032

Forms 4 and 5

Insider transactions

30 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2022-08-12	Epizyme, Inc.D Disposition to Issuer	See Remarks	DDisposition to Issuer	−30.2K sh	—	—	21,895
2022-08-12	Epizyme, Inc.D Disposition to Issuer	See Remarks	DDisposition to Issuer	−21.9K sh	—	—	0
2022-08-09	Epizyme, Inc.M Exercise/Conversion	See Remarks	MExercise/Conversion	+300K sh	$1.39	+$417K	330,963
2022-08-09	Epizyme, Inc.F Tax Payment	See Remarks	FTax Payment	−280K sh	$1.39	−$389K	51,099
2022-08-09	Epizyme, Inc.Stock Option (Right to Buy)M Exercise/Conversion	See Remarks	MExercise/Conversion	−300K sh	—	—	0
2022-03-17	Epizyme, Inc.Stock Option (Right to Buy)A Award	See Remarks	AAward	+300K sh	—	—	300,000
2022-02-28	Epizyme, Inc.A Award	See Remarks	AAward	+2,331 sh	$1.27	+$2,952.212	30,963
2022-02-07	Epizyme, Inc.S Sale	See Remarks	SSale	−222 sh	$1.50	−$333	28,632
2022-02-02	Epizyme, Inc.S Sale	See Remarks	SSale	−687 sh	$1.37	−$941.19	28,854
2021-08-16	Epizyme, Inc.A Award	See Remarks	AAward	+14.8K sh	—	—	28,264
2021-08-16	Epizyme, Inc.Stock Option (Right to Buy)A Award	See Remarks	AAward	+22.3K sh	—	—	22,250
2021-02-04	Epizyme, Inc.S Sale	See Remarks	SSale	−227 sh	$11.21	−$2,544.67	13,431
2021-02-01	Epizyme, Inc.A Award	See Remarks	AAward	+7,700 sh	—	—	13,658
2021-02-01	Epizyme, Inc.Stock Option (Right to Buy)A Award	See Remarks	AAward	+11.6K sh	—	—	11,550
2020-09-02	Epizyme, Inc.S Sale	See Remarks	SSale	−543 sh	$12.88	−$6,993.84	5,958
2020-09-01	Epizyme, Inc.Stock Option (Right to Buy)A Award	See Remarks	AAward	+6,650 sh	—	—	6,650
2020-06-26	Epizyme, Inc.S Sale	See Remarks	SSale	−317 sh	$16.15	−$5,119.55	4,838
2020-06-25	Epizyme, Inc.A Award	See Remarks	AAward	+1,050 sh	—	—	5,155
2020-03-25	Epizyme, Inc.S Sale	See Remarks	SSale	−212 sh	$15.28	−$3,239.36	4,961
2020-03-24	Epizyme, Inc.A Award	See Remarks	AAward	+1,556 sh	—	—	5,173
2020-03-24	Epizyme, Inc.A Award	See Remarks	AAward	+700 sh	—	—	4,105
2020-03-03	Epizyme, Inc.S Sale	See Remarks	SSale	−996 sh	$22.18	−$22.1K	3,617
2020-02-03	Epizyme, Inc.A Award	See Remarks	AAward	+2,575 sh	—	—	3,617
2020-02-03	Epizyme, Inc.Stock Option (Right to Buy)A Award	See Remarks	AAward	+11.6K sh	—	—	11,588
2020-01-24	Epizyme, Inc.S Sale	See Remarks	SSale	−330 sh	$24.63	−$8,127.9	1,042
2020-01-23	Epizyme, Inc.A Award	See Remarks	AAward	+875 sh	—	—	1,372
2019-09-03	Epizyme, Inc.S Sale	See Remarks	SSale	−971 sh	$12.77	−$12.4K	6,501
2019-06-13	Epizyme, Inc.S Sale	See Remarks	SSale	−203 sh	$12.10	−$2,456.3	497
2019-06-12	Epizyme, Inc.A Award	See Remarks	AAward	+700 sh	—	—	700
2019-01-24	Epizyme, Inc.Stock Option (Right to Buy)A Award	See Remarks	AAward	+24.5K sh	—	—	24,523

Recent filings

Accepted (ET)
Aug 164
Beaulieu Joseph0000899243-22-028859
SEC(opens sec.gov)
Aug 114
Beaulieu Joseph0000899243-22-028418
SEC(opens sec.gov)
Mar 214
Beaulieu Joseph0000899243-22-011728
SEC(opens sec.gov)
Feb 94
Beaulieu Joseph0000899243-22-005473
SEC(opens sec.gov)
Feb 44
Beaulieu Joseph0000899243-22-004826
SEC(opens sec.gov)
Aug 184
Beaulieu Joseph0000899243-21-033404
SEC(opens sec.gov)
Feb 54
Beaulieu Joseph0000899243-21-005039
SEC(opens sec.gov)
Feb 24
Beaulieu Joseph0000899243-21-004521
SEC(opens sec.gov)
Sep 34
Beaulieu Joseph0000899243-20-024203
SEC(opens sec.gov)
Jun 304
Beaulieu Joseph0000899243-20-017906
SEC(opens sec.gov)
Jun 304/A
Beaulieu Joseph0000899243-20-017865
SEC(opens sec.gov)

Companies

Epizyme, Inc.See Remarks

Address

C/O EPIZYME, INC., 400 TECHNOLOGY SQUARE

CAMBRIDGE, MA, 02139